The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases-Reference-Cited by-同舟云学术

The efficacy, safety, and feasibility of inhaled amikacin for the treatment of difficult-to-treat non-tuberculous mycobacterial lung diseases

Published:2017-08-09 Issue:1 Volume:17 Page:
ISSN:1471-2334
Container-title:BMC Infectious Diseases
language:en
Short-container-title:BMC Infect Dis

Author:

Yagi Kazuma,Ishii Makoto^ORCID,Namkoong Ho,Asami Takahiro,Iketani Osamu,Asakura Takanori,Suzuki Shoji,Sugiura Hiroaki,Yamada Yoshitake,Nishimura Tomoyasu,Fujiwara Hiroshi,Funatsu Yohei,Uwamino Yoshifumi,Kamo Tetsuro,Tasaka Sadatomo,Betsuyaku Tomoko,Hasegawa Naoki

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases

Link

http://link.springer.com/content/pdf/10.1186/s12879-017-2665-5.pdf

Reference23 articles.

1. Adjemian J, Olivier KN, Seitz AE, Holland SM, Prevots DR. Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries. Am J Respir Crit Care Med. 2012;185(8):881–6.

2. Ringshausen FC, Apel RM, Bange FC, de Roux A, Pletz MW, Rademacher J, Suhling H, Wagner D, Welte T. Burden and trends of hospitalisations associated with pulmonary non-tuberculous mycobacterial infections in Germany, 2005-2011. BMC Infect Dis. 2013;13:231.

3. Hoefsloot W, van Ingen J, Andrejak C, Angeby K, Bauriaud R, Bemer P, Beylis N, Boeree MJ, Cacho J, Chihota V, et al. The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples: an NTM-NET collaborative study. Eur Respir J. 2013;42(6):1604–13.

4. Kendall BA, Winthrop KL. Update on the epidemiology of pulmonary nontuberculous mycobacterial infections. Semin Respir Crit Care Med. 2013;34(1):87–94.

5. Namkoong H, Kurashima A, Morimoto K, Hoshino Y, Hasegawa N, Ato M, Mitarai S. Epidemiology of Pulmonary Nontuberculous Mycobacterial Disease, Japan(1). Emerg Infect Dis. 2016;22(6):1116–7.

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nitric oxide-releasing prodrug for the treatment of complex Mycobacterium abscessus infections;Antimicrobial Agents and Chemotherapy;2024-02-07

2. Comparing minimum inhibitory concentrations of amikacin for pulmonary Mycobacterium avium complex disease: An analysis of culture media differences;Journal of Infection and Chemotherapy;2024-02

3. Analyse pharmacologique du traitement des pneumopathies à Mycobacterium abscessus;Revue des Maladies Respiratoires;2024-01

4. Nontuberculous Mycobacterium Infections in Lung Disease and Medical Interventions;Diagnosis of Mycobacterium;2023

5. Primates;Carpenter's Exotic Animal Formulary;2023